Dexxon Holdings Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 5,408 shares at $6.79 ($37K) on 2019-05-16, disclosed to the SEC on 2019-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| UROV | BUY | 2019-05-23 | $170K | — | Filing → |
| AXON | BUY | 2019-03-19 | $20.0M | — | Filing → |
| AXON | BUY | 2018-12-20 | $10.0M | — | Filing → |